Master Cell Bank– tag –
-
REPROCELL Offers High-Quality Clinical-Grade iPSC Services with Proprietary StemRNA™ 3rd Gen Technology, Including Reprogramming, Differentiation, and Gene Editing
REPROCELL Japan Overview REPROCELL provides comprehensive, high-quality iPSC reprogramming, differentiation, and gene editing services utilizing its proprietary StemRNA™ 3rd Gen Reprogramming technology. These services encompass efficien... -
Retinal Diseases Emerge as Key Proving Ground for Next-Gen iPSC Regenerative Therapies, BioProcess International Reports
BioProcess International USA Overview BioProcess International reports that iPSC-derived regenerative therapies are increasingly seen as the primary proving ground for next-generation treatments in retinal diseases. iPSCs enable scalable... -
Liv Hospital Details Advanced ‘Off-the-Shelf’ CAR-T Manufacturing, Promising Scalability and Broader Access
Liv Hospital Turkey Overview Liv Hospital has unveiled its detailed manufacturing process for allogeneic, 'off-the-shelf' CAR-T cell therapy, a significant leap towards overcoming the logistical and cost barriers of current personalized ... -
Allogeneic Cell Therapy Manufacturing: Broad Applicability, Scalability, and Automation Driving Future Advances
Industry Informational Article USA Overview This article provides a comprehensive overview of allogeneic cell therapy manufacturing, highlighting its advantages over autologous approaches, including broader applicability, superior scalab...
1